Dr. Steve Ramirez is revealing where memories “live” in the brain, and explores how traumatic memories might be therapeutically modified.

Dr. Mark S. George, a pioneer in the field, explains how TMS and related non-invasive brain stimulation technologies are changing the face of psychiatry.

Dr. Vikaas Sohal and colleagues have used advanced technologies to discover biological processes that are likely involved in causing cognitive dysfunction in schizophrenia. The road to bold new treatments is being paved with this new knowledge.

Eating Disorders (EDs) are among the most prevalent psychiatric disorders yet also among the most misunderstood. Dr. Cynthia Bulik, a BBRF Distinguished Investigator, explains her research indicating that anorexia nervosa, the most deadly ED, is also a disorder of the body's metabolic system.

We write about a novel idea to address brain-based disorders that has moved from theory to bedside in only 3 years. Called closed-loop neuromodulation, it involves using electrical stimulation—delivered via an implanted deep-brain stimulation (DBS) device—at a precise location in the brain. The

Research on COVID’s impacts indicates how the pandemic is affecting families and child mental health, as well as how racial and socioeconomic factors can exacerbate risk and pose obstacles to care for those who are underserved by the healthcare system.

In-depth discussion summarizing some of the most important findings to date about the possibility of using psychedelic compounds to treat individuals with psychiatric illness. We feature comments from experts in the field (several of them members of BBRF’s Scientific Council), who have been

Lynnette Averill, Ph.D., a clinical psychologist affiliated with the Baylor College of Medicine, Yale University, and the Department of Veterans Affairs, studies the causes and consequences of trauma-related psychopathology and suicidality, and is investigating novel rapid-acting interventions.

We offer A RESEARCHER’S PERSPECTIVE, based on a presentation given by Lisa M. Monteggia, Ph.D., of Vanderbilt University, at a zoom event hosted by BBRF. The topic of her presentation was “Studying Ketamine’s Rapid Effects to Unlock Secrets for Developing Better Antidepressants

Our PATHWAYS TO THE FUTURE story is about an unconventional approach to developing new psychiatric drugs. Based on an initiative by the National Institute of Mental Health, it’s called “Fast-Fail” and is designed to weed out the weakest drug candidates early in the process, to